[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100566611":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":10,"centralContacts":12,"locations":18,"responsibleParty":33,"collaborators":10,"id":35,"slug":10,"hasResults":36,"nctId":37,"briefTitle":38,"officialTitle":38,"acronym":10,"eligibilityCriteria":39,"healthyVolunteers":36,"sex":40,"minAge":41,"maxAge":10,"enrollmentInfo":42,"targetDuration":10,"studyType":45,"phases":10,"briefSummary":46,"conditions":47,"keywords":53,"overallStatus":20,"whyStopped":10,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Shanghai Mental Health Center","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"Patients and their caregivers",null,"Patients (and their caregivers) with psychiatric disorders for which risperidone is indicated, including schizophrenia, bipolar disorder, autism spectrum disorder, conduct disorder, and mental retardation.",[13],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},"Lan Luo, Doctor of Medicine","CONTACT","+8618516544150","lan-luo@foxmail.com",[19],{"facility":5,"status":20,"city":21,"state":22,"zip":23,"country":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"RECRUITING","Shanghai","Shanghai Municipality","200030","China",{"type":26,"coordinates":27},"Point",[28,29],121.45806,31.22222,{"lat":29,"lon":28},[32],{"name":14,"role":15,"phone":16,"phoneExt":10,"email":17},{"type":34,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100566611",false,"NCT06657430","A Study on the Preference of Risperidone Dosage Forms","Inclusion Criteria:\n\n* Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.\n\nExclusion Criteria:\n\n* Have difficulty reading and understanding Chinese or refuse to participate in the study.","ALL","18 Years",{"count":43,"type":44},1000,"ESTIMATED","OBSERVATIONAL","This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.",[48,49,50,51,52],"Schizophrenia","Bipolar Affective Disorder","Autism Spectrum Disorder","Conduct Disorder","Mental Retardation",[54,55,56,57],"risperidone","patch","cross-sectional study","preference","2024-10-23",{"date":60,"type":61},"2024-10-24","ACTUAL",{"date":63,"type":61},"2024-09-19",{"date":65,"type":44},"2025-02-28",{"name":5,"class":6},1]